New Materials to Deliver Medicines Inside Cells for Cartilage Diseases
Computation-aided Molecular Design of DNA-Inspired Janus Base Biomaterials for Intracellular Delivery
This work aims to create special new materials that can safely carry important RNA medicines directly into cells to help treat conditions like cartilage diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Storrs NIH-funded |
| Lab location | 1 site (Storrs-Mansfield, United States) |
| Project ID | NIH-11192867 on NIH RePORTER |
What this research studies
Many promising RNA medicines, including those for inflammation or gene editing, need to get inside cells to work properly, but this is a big challenge. Current delivery methods often fail because the medicines get trapped or destroyed before reaching their target within the cell. Our team is designing innovative, DNA-inspired materials using computer models to improve how these RNA medicines are delivered. We want to make sure the medicines can successfully enter cells and avoid being broken down, both at the cellular level and when given throughout the body. This approach could lead to more effective treatments for various diseases.
Who could benefit from this research
Good fit: Patients who might benefit from future RNA-based therapies for cartilage diseases or other conditions requiring targeted medicine delivery into cells are the ultimate beneficiaries of this foundational work.
Not a fit: Patients whose conditions are not targeted by RNA-based therapies or who do not require intracellular drug delivery may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to more effective ways to deliver RNA-based medicines, potentially improving treatments for cartilage diseases and other conditions requiring precise cellular delivery.
How similar studies have performed: While existing methods like lipid nanoparticles are used for mRNA delivery, this project explores novel DNA-inspired biomaterials and computational design to overcome current limitations in effectiveness.
Where this research is happening
Storrs-Mansfield, United States
- University of Connecticut Storrs — Storrs-Mansfield, United States (Active)
Researchers
- Principal investigator: Chen, Yupeng — University of Connecticut Storrs
- Study coordinator: Chen, Yupeng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.